Vallis Capital Partners

RACLAC SA is a Portuguese company based in Vila Nova De Famalicão, established in 2007. It focuses on the development, manufacture, commercialization, and export of disposable products tailored for the health, industrial, and aesthetic sectors. The company offers a diverse range of products, including aprons, bibs, caps, coveralls, dermocosmetics, gloves, examination supplies, masks, non-surgical and surgical gowns, shoe covers, and various items for spas and beauty centers. RACLAC SA's products cater to multiple environments, such as hospitals, clinics, nursing homes, day care centers, laboratories, and industries including food, pharmaceuticals, and mechanical sectors.

Vortal is a leading G2B2B (Government to Business to Business) eMarketplace operator, serving more than 50,000 companies and 2,000 contracting authorities in 3 continents. The company was founded in 2000 with a mission “to help our clients buying better and selling more", to achieve superior performance” in a high performance collaborative cloud-based solution. Vortal supports its customers through its offices in Portugal, Spain, UK and the Czech Republic , with a team of highly-motivated people from 7 nationalities. Business foundation has been built on becoming the leader in Portugal, both in the Private and Public markets regarding electronic procurement. Since 2010, Vortal has been consecutively distinguished as one of "100 best companies to work in Portugal", in a survey carried out by “Accenture" and "Exame" magazine. In 2011, the Association of Electronic Commerce and Interactive Advertising distinguished Vortal as the "Best B2B e-commerce website". At an International level, Vortal was included in the Deloitte “Technology fast growing 500 EMEA ranking” and recognized by Gartner regarding expertise and capabilities, namely in the publications “Strategies for Public-Sector Investment in Procurement Applications" and "Cool Vendors in Procurement Applications".

CGC Genetics is a medical genetics services provider based in Porto, Portugal, specializing in a range of diagnostic testing solutions. The company offers services in clinical genomics, molecular diagnostics, cytogenetics, prenatal screening, and anatomic pathology. Through advanced technological capabilities, CGC Genetics delivers gene testing, chromosomal analysis using microarray-comparative genomic hybridization, and various molecular diagnostic tests. By focusing on reliability and affordability, CGC Genetics aims to enhance patient care through accurate lab testing and medical diagnostic imaging services.